Anti-Fas抗体(ab110021)
Key features and details
- Goat polyclonal to Fas
- Suitable for: WB, IHC-P
- Reacts with: Human
- Isotype: IgG
选择批间可重复性更高的重组抗体
- 研究可靠 —— 各批次间结果一致且可重复
- 长期批量供应 —— 采用重组技术,可实现快速生产
- 首次实验即可成功 —— 经过大量验证确认了特异性
- 符合伦理标准 —— 产品不含动物成分
概述
-
产品名称
Anti-Fas抗体
参阅全部 Fas 一抗 -
描述
山羊多克隆抗体to Fas -
宿主
Goat -
经测试应用
适用于: WB, IHC-Pmore details -
种属反应性
与反应: Human
预测可用于: Macaque monkey -
免疫原
Synthetic peptide corresponding to Human Fas aa 150-250 (internal sequence). Synthetic peptide:
KTCRKHRKENQGSH
, corresponding to internal sequence amino acids 197-210 of Human Fas -
阳性对照
- Human small intestine tissue, Human tonsil tissue, MOLT4 cell lysate.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles. -
存储溶液
pH: 7.30
Preservative: 0.02% Sodium azide
Constituents: Tris buffered saline, 0.5% BSA -
Concentration information loading...
-
纯度
Immunogen affinity purified -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab110021于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
WB |
Use a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 38 kDa.
|
|
IHC-P |
Use a concentration of 3.75 µg/ml.
|
说明 |
---|
WB
Use a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 38 kDa. |
IHC-P
Use a concentration of 3.75 µg/ml. |
靶标
-
功能
Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro). -
组织特异性
Isoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6. -
疾病相关
Defects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly. -
序列相似性
Contains 1 death domain.
Contains 3 TNFR-Cys repeats. -
结构域
Contains a death domain involved in the binding of FADD, and maybe to other cytosolic adapter proteins. -
细胞定位
Secreted and Cell membrane. - Information by UniProt
-
数据库链接
- Entrez Gene: 355 Human
- Omim: 134637 Human
- SwissProt: P25445 Human
- Unigene: 244139 Human
-
别名
- ALPS 1A antibody
- ALPS1A antibody
- APO 1 antibody
see all
图片
-
ab110021, staining CD95 in Human small intestine tissue by immunohistochemistry.
-
ab110021, staining CD95 in Human tonsil tissue by immunohistochemistry.
-
Anti-Fas antibody (ab110021) at 0.1 µg/ml + MOLT4 cell lysate (in RIPA buffer) at 35 µg
Predicted band size: 38 kDa
Primary incubation was 1 hour. Detected by chemiluminescence.
数据表及文件
-
SDS download
-
Datasheet download
文献 (2)
ab110021 被引用在 2 文献中.
- Yang H et al. Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways. World J Gastrointest Oncol 11:377-392 (2019). PubMed: 31139308
- Huang W et al. Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin. Oncotarget 9:25891-25902 (2018). PubMed: 29899829